Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

Library Archives
Volume 26, 2022 Archive

Six issues from 2022 in one convenient archive.

This archive contains the following articles listed by volume, issue and page number:

Issues Included
Issue/Volume Title
January/February 2022
Vol. 26 No. 1
Volume 26, Number 1
March/April 2022
Vol. 26 No. 2
Volume 26, Number 2
May/June 2022
Vol. 26 No. 3
Volume 26, Number 3
July/August 2022
Vol. 26 No. 4
Volume 26, Number 4
September/October 2022
Vol. 26 No. 5
Volume 26, Number 5
November/December 2022
Vol. 26 No. 6
Volume 26, Number 6

Volume 26, 2022 Articles
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
PreScription: IJPC--Starting Year 26
Allen Loyd V Jr
Jan/Feb 2022
Pg. 4

Compounded Melatonin Cream for the Prevention and Treatment of Radiation Dermatitis: A Case Report
Garcia-Segura Laura Corral
, Garcia-Segura Javier Corral, Delgado Carlos Dorado, Maldonaldo Nuria Romero, Salgado Elena Cardero, Llorens Lucía Pérez
Jan/Feb 2022
Pg. 6-8

Pharmacy Student Satisfaction and Perceptions Following a Virtual Sterile Compounding Experience
Mohammad Insaf
, Lobkovich Alison, Nardolillo Joseph, Wilhelm Shelia
Jan/Feb 2022
Pg. 10-17

A Compendium of Compounding Agents and Formulations, Part 1: Melatonin
Riepl Mike
Jan/Feb 2022
Pg. 18-23

Editorial: Should All Pharmacists Compound?
Allen Loyd V Jr
Jan/Feb 2022
Pg. 24-28

Everything Old is New Again
Brunner Scott
Jan/Feb 2022
Pg. 30-32

Basics: Considerations and Background Information for Counseling Patients Using Compounded Suppositories
Allen Loyd V Jr
Jan/Feb 2022
Pg. 34-38

Sterile Basics: Compounding Sterile Preparations with Cyclodextrins
Allen Loyd V Jr
Jan/Feb 2022
Pg. 41-49

Calculations
Stockton Shelly J
Jan/Feb 2022
Pg. 50

Aluminum Chloride 6.25% in Anhydrous Alcohol
Allen Loyd V Jr
Jan/Feb 2022
Pg. 52

Ascorbic Acid 10% in Anhydrous PEG ointment
Allen Loyd V Jr
Jan/Feb 2022
Pg. 53

Deoxyarbutin 3% Anhydrous Emulsion
Allen Loyd V Jr
Jan/Feb 2022
Pg. 54

Diclofenac Sodium 1%-15% Topical Gel
Allen Loyd V Jr
Jan/Feb 2022
Pg. 55

Enalapril Maleate 1 mg-mL in Ora-Plus and Ora-Sweet Suspension
Allen Loyd V Jr
Jan/Feb 2022
Pg. 56

Mometasone Furoate 0.1% Lotion
Allen Loyd V Jr
Jan/Feb 2022
Pg. 57

Capsule Machine Validation
Al-Achi Antoine
, McGreggor Tysheon, Jaligama Shreelekha, Friday Kafi, Alyami Hussain
Jan/Feb 2022
Pg. 58-64

Physical Stability and Release Profile of Compounded Gabapentin Containing Pluronic Lecithin Organogel for Neuropathic Pain Management
Hong Eun Ji
, Sumanasekera Wasana, Le Uyen Minh
Jan/Feb 2022
Pg. 65-71

Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding (Reprint)
Soefje Scott
, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P
Jan/Feb 2022
Pg. 72-79

Investigation of the Effects of Excipients in the Compounding of Amlodipine Besylate Orally Disintegrating Tablets
Azmi Nurual Hanisah Saiful
, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam, Bin Liew Kai
Jan/Feb 2022
Pg. 80-87

PreScription: Comments on the FDA Guidance "Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act: Guidance for Industry"
Allen Loyd V Jr
Mar/Apr 2022
Pg. 92

A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin
Riepl Mike
Mar/Apr 2022
Pg. 94-98

Allowing Compounding Pharmacies to Address Drug Shortages
Broughel James
Mar/Apr 2022
Pg. 100-109

The Potential Effects of a Compounded Methylcobalamin Nasal Spray on Short-term Memory Loss After Intracranial Hemorrhage: A Case Report
Good Lauren
, Lieu Yi, Banov Fabiana, Harger Beau, Banov Daniel
Mar/Apr 2022
Pg. 110-115

Quality Control: Photodocumentation in Pharmacy Compounding
Allen Loyd V Jr
Mar/Apr 2022
Pg. 116-117

Basics of Compounding: Compounding Nonsterile Preparations Using Cyclodextrins
Allen Loyd V Jr
Mar/Apr 2022
Pg. 118-126

Sterile Basics of Compounding: Methods of Sterilization and Depyrogenation
Allen Loyd V Jr
Mar/Apr 2022
Pg. 129-136

Calculations
Stockton Shelly J
Mar/Apr 2022
Pg. 138

Alprazolam 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Mar/Apr 2022
Pg. 140

Codeine Phosphate 3 mg/mL in Ora-Sweet
Allen Loyd V Jr
Mar/Apr 2022
Pg. 141

Ketoconazole 2%, Terbenafine 1%, Acetic Acid 2%, and Urea 2% in Dimethyl Sulfoxide Nail Polish
Allen Loyd V Jr
Mar/Apr 2022
Pg. 142

Lorazepam 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2022
Pg. 143

Mesalamine 100-mg/mL Suspension Enema
Allen Loyd V Jr
Mar/Apr 2022
Pg. 144

Naproxen 25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2022
Pg. 145

Phenobarbital 10 mg/mL in SyrSpend SF pH4, Cherry Flavored
Allen Loyd V Jr
Mar/Apr 2022
Pg. 146

Phenytoin 15 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2022
Pg. 147

Propranolol 2 mg/mL and 5 mg/mL in Ora-Blend SF Suspension
Allen Loyd V Jr
Mar/Apr 2022
Pg. 148

Pyridoxine Hydrochloride 50 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2022
Pg. 149

Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates)
Brandin Thibaut
, Wasilewski Maya, Panuccio Camille, Bouguergour Cyrielle, Primas Nicolas, Lamy Edouard, Jean Christophe, Bertault-Peres Pierre, Rathelot Pascal, Curti Christophe, Vanelle Patrice
Mar/Apr 2022
Pg. 150-154

Comparison of Solvent Casting and Spray Casting Method on Compounding of an Orally Disintegrating Film Containing Amlodipine Besylate
Ruslan Mohamad Fariz Haiqal
, Janakiraman Ashok Kumar, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam, Bin Liew Kai
Mar/Apr 2022
Pg. 155-162

Molding as Innovative Technology for Personalized Tablet Production
Mady Omar Y
, Al-Shoubki Adam A, Hagag Youssef, Ibrahim Bakry, Donia Ahmed A
Mar/Apr 2022
Pg. 163-174

PreScription: Standing in the Gap
Allen Loyd V Jr
May/Jun 2022
Pg. 180

Art of Pharmacy v. State
Standridge Rob
May/Jun 2022
Pg. 182-186

A Compendium of Compounding Agents and Formulations, Part 3: Gentamicin Sulfate and Benzoyl Peroxide
Riepl Mike
May/Jun 2022
Pg. 189-193

A Procedure for Tablet Production by Using the 3D Molding Technology and Powder Micromeritics Properties
Mady Omar
May/Jun 2022
Pg. 195-200

Compounding for Investigational and Clinical Studies
Allen Loyd V Jr
May/Jun 2022
Pg. 201-209

Three Things You Need to Know Right Now
Brunner Scott
May/Jun 2022
Pg. 211-213

Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes
Allen Loyd V Jr
May/Jun 2022
Pg. 214-217

Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection
Allen Loyd V Jr
May/Jun 2022
Pg. 219-228

Calculations
Stockton Shelly J
May/Jun 2022
Pg. 230

Alendronate Sodium 1% Topical Dental Gel
Allen Loyd V Jr
May/Jun 2022
Pg. 232

Azstarys in Ora-Blend Single Dose
Allen Loyd V Jr
May/Jun 2022
Pg. 233

Candesartan Cilexitil 1 mg/mL Syrup
Allen Loyd V Jr
May/Jun 2022
Pg. 234

Chloral Hydrate 70 mg/mL Syrup
Allen Loyd V Jr
May/Jun 2022
Pg. 235

Cinnarizine 1 mg/mL in Oral Medium-Chain Triglycerides Anhydrous Vehicle
Allen Loyd V Jr
May/Jun 2022
Pg. 236

Clobazam 1 mg/mL in Oral-Mix Suspension
Allen Loyd V Jr
May/Jun 2022
Pg. 237

Metronidazole 7.5 mg/mL Topical Oil-in-Water Microemulsion
Allen Loyd V Jr
May/Jun 2022
Pg. 238

Nitrazepam 1 mg/mL Oral Solution
Allen Loyd V Jr
May/Jun 2022
Pg. 239

Sirolimus 0.1% Ointment
Allen Loyd V Jr
May/Jun 2022
Pg. 240

Valganciclovir 20 mg/mL in Ora-Plus and Ora-Sweet Suspension
Allen Loyd V Jr
May/Jun 2022
Pg. 241

Finding the Right Balance: A Nationwide Study of Student Pharmacist Exposure to and Perceptions of Nonsterile Compounding
Fredrickson Mary E
, Belcher Faith G, Del Vecchio Kamryn N, Galleher Miranda N, Jugo Leila S, Gothard M David, Pallotta Raneem H, Pallotta Victor A Jr
May/Jun 2022
Pg. 242-247

Physical and Chemical Stability of Pharmaceutical Preparation of Bumetanide and Scopolamine
Catry Emilie
, Colsoul Marie-Louise, Closset Melanie, Hubert Justine, Soumoy Laura, Bihin Benoit, Thiry Emmanuell, Jamart Jacques, Hecq Jean-Daniel, Galanti Laurence
May/Jun 2022
Pg. 248-254

Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets
Liew Kai Bin
, Hii Shou Hui, Chew Yik Ling, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam
May/Jun 2022
Pg. 255-263

PreScription: Pharmacy and Drug Information
Allen Loyd V Jr
Jul/Aug 2022
Pg. 268

A Compendium of Compounding Agents and Formulations, Part 4: Nifedipine and Pentoxifylline
Riepl Mike
Jul/Aug 2022
Pg. 270-274

Compounding with Pracaxi Versus Copaiba Oil
Magutu Tom
Jul/Aug 2022
Pg. 277-281

Evaluation of the Physical-chemical Characteristics and Biopharmaceutical Performance of Dilu-Cap: A Complete Line of Excipients for Hard-shell Capsules
de Oliveira Ferreira Anderson
, Polonini Hudson
Jul/Aug 2022
Pg. 283-291

Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases
Harrington Amy
, Williams LaVonn
Jul/Aug 2022
Pg. 293-296

The Role of Compounding Pharmacists During Drug Shortages
Ofei Kelvin
Jul/Aug 2022
Pg. 298-301

Basics: Hollow-type Suppositories
Allen Loyd V Jr
Jul/Aug 2022
Pg. 302-307

Sterile Basics of Compounding: How to Implement a Robust Visual-inspection Program
Summers Amy
Jul/Aug 2022
Pg. 309-315

Calculations
Stockton Shelly J
Jul/Aug 2022
Pg. 316

Betamethasone Dipropionate 0.05% and Salicylic Acid 3% Lotion
Allen Loyd V Jr
Jul/Aug 2022
Pg. 318

Cetrimide Lotion
Allen Loyd V Jr
Jul/Aug 2022
Pg. 319

Dexamethasone 1 mg/mL in Oral Mix
Allen Loyd V Jr
Jul/Aug 2022
Pg. 320

Furosemide 5-mg/mL Oral Suspension
Allen Loyd V Jr
Jul/Aug 2022
Pg. 321-322

Hydralazine Hydrochloride 10 mg/mL Oral Liquid
Allen Loyd V Jr
Jul/Aug 2022
Pg. 323-324

Indomethacin 1% Topical Gel
Allen Loyd V Jr
Jul/Aug 2022
Pg. 325-326

Nystatin 250,000-unit Frozen Popsicles
Allen Loyd V Jr
Jul/Aug 2022
Pg. 327

Povidone Iodine 100-mg/mL Solution/Spray
Allen Loyd V Jr
Jul/Aug 2022
Pg. 328

Psoriasis Topical Ointment
Allen Loyd V Jr
Jul/Aug 2022
Pg. 329

Physicochemical and Microbiological Stability of Vancomycin 10-mg/mL Intravitreal Syringes
Bartoll Aaron Puplà
, Bellés Medall Maria Dolores, Peñarrocha Josep Edo, Escrig Laura Solaz, Clemente Ruben Eguren, Azuara Julia Bodega, Piqueres Raul Ferrando
Jul/Aug 2022
Pg. 330-335

Long-term Stability of Epitheliotropic Factors in Frozen Serum Eye Drops
Sahyoun Jean-Yves
, Cloutier Marc, Frenette Mathieu, Robert Marie-Claude
Jul/Aug 2022
Pg. 336-341

Physicochemical and Microbiological Stability of Amitriptyline Hydrochloride Oral Liquid Dosage Forms in PCCA Base, SuspendIt
Pramar Yashoda V
, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
Jul/Aug 2022
Pg. 342-351

PreScription: A New Dosage Form
Allen Loyd V Jr
Sep/Oct 2022
Pg. 356

Hazardous Drug Enteral Device: A Closed System Device for Crushing and Dispersing Hazardous Drug Tablets for Enteral Administration
Lopez C Vidal
, Rios GL Quito
Sep/Oct 2022
Pg. 358-362

A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans
Riepl Mike
Sep/Oct 2022
Pg. 364-368

Recent Formulation Advances and Preparation of Orally Disintegrating Tablets
Ejeta Fikadu
Sep/Oct 2022
Pg. 370-377

Compounded Medications and Probiotics for Irritable Bowel Syndrome
Narváez Katherine Rivera
, Thompson Tara
Sep/Oct 2022
Pg. 378-384

Compounding with Biotechnology Products, Part 1: General Considerations
Allen Loyd V Jr
Sep/Oct 2022
Pg. 385-395

The FDA is in a Hole. It Should Stop Digging.
Brunner Scott
Sep/Oct 2022
Pg. 396-398

Basics of Compounding: Compounding with Microneedle Arrays, Part 1: Introduction and Overview
Allen Loyd V Jr
Sep/Oct 2022
Pg. 400-408

Sterile Basics of Compounding: Contamination Control Strategies, Part 1
Summers Amy
Sep/Oct 2022
Pg. 411-418

Calculations
Stockton Shelly J
Sep/Oct 2022
Pg. 420

Amphotericin B 3% Otic Gel
Allen Loyd V Jr
Sep/Oct 2022
Pg. 422

Ascorbic acid 5% Topical Microemulsion
Allen Loyd V Jr
Sep/Oct 2022
Pg. 423

Chlorhexidine Diacetate 2% Topical Gel
Allen Loyd V Jr
Sep/Oct 2022
Pg. 424

Clindamycin Hydrochloride 10-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 2022
Pg. 425

Clotrimazole 10-mg Troches
Allen Loyd V Jr
Sep/Oct 2022
Pg. 426

Cysteamine Hydrochloride 100 mg/mL Oral Solution
Allen Loyd V Jr
Sep/Oct 2022
Pg. 427

Hydrogen Peroxide 1.5% with Sodium Fluoride 0.5-mg/mL Oral Rinse
Allen Loyd V Jr
Sep/Oct 2022
Pg. 428

Lansoprazole 3-mg/mL in Ora-Blend Suspension
Allen Loyd V Jr
Sep/Oct 2022
Pg. 429

Metronidazole 10%, Nifedipine 0.5%, Lidocaine 1.5%, and Diclofenac 3% Ointment
Allen Loyd V Jr
Sep/Oct 2022
Pg. 430

Methylcobalamin 2-mg/mL Nasal Spray
Allen Loyd V Jr
Sep/Oct 2022
Pg. 431

Effectiveness of a New Ultraviolet C Disinfection System to Inactivate Airborne Coronavirus in Different Environmental Conditions
Marianni Bruna
, Polonini Hudson
Sep/Oct 2022
Pg. 432-435

Effects of Calcium Polystyrene Sulfonate Formulation Change from Dry Syrup to Oral Solution in Patients with Chronic Kidney Disease
Kobayashi Shunsuke
, Ogawara Yuka, Imamura Yoshihiko, Kitaoka Akira, Yasu Takeo
Sep/Oct 2022
Pg. 436-439

PreScription: Compounded Drugs Often Become Manufactured Drugs
Allen Loyd V Jr
Nov/Dec 2022
Pg. 444

Compounding with Biotechnology Products, Part 2: Product-specific Considerations
Allen Loyd V Jr
Nov/Dec 2022
Pg. 446-466

Unlicensed Transdermal Medications in Feline Patients: Three Case Reports
Urwin Craig
, Jean Linda, Carvalho Maria, Robson-Laws Michael
Nov/Dec 2022
Pg. 468-472

Pharmacogenomics as a Competitive Strategy for Compounding Pharmacies
Maham Nicole Y
Nov/Dec 2022
Pg. 474-479

A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing
Riepl Mike
Nov/Dec 2022
Pg. 480-488

Compounding with Microneedle Arrays, Part 2: Preparation and Administration Methods
Allen Loyd V Jr
Nov/Dec 2022
Pg. 490-495

Sterile Basics of Compounding: Contamination Control Strategies, Part 2
Summers Amy
Nov/Dec 2022
Pg. 497-504

Calculations
Stockton Shelly J
Nov/Dec 2022
Pg. 506

Bacitracin 0.01% and Phenol 0.1% in Cetaphil Lotion
Allen Loyd V Jr
Nov/Dec 2022
Pg. 508

Curcumin 2% Topical Gel
Allen Loyd V Jr
Nov/Dec 2022
Pg. 509

Diazoxide 10-mg/mL in Oral Mix SF
Allen Loyd V Jr
Nov/Dec 2022
Pg. 510

Enrofloxacin 11.35 mg/mL in Ora-Blend, Veterinary
Allen Loyd V Jr
Nov/Dec 2022
Pg. 511

Flucytosine 50 mg/mL in Oral-Sweet and Ora-Plus
Allen Loyd V Jr
Nov/Dec 2022
Pg. 512

Granisetron Hydrochloride 005 mg/mL in Ora-Sweet and Ora-Plus
Allen Loyd V Jr
Nov/Dec 2022
Pg. 513

Miller's Modified Mouthwash
Allen Loyd V Jr
Nov/Dec 2022
Pg. 514

Potassium Alum 1% Bladder Irrigation for Hemorrhagic Cystitis (Low-Medium Risk Compounding)
Allen Loyd V Jr
Nov/Dec 2022
Pg. 515

Formulation Development of Modafinil Sprinkle Dosage Form: Study on the Effect of Food on Dosage
Kumaravelrajan Rajagopal
, Karthik B, Venkatasan Suba
Nov/Dec 2022
Pg. 516-521

Intravenous Physical Compatibility of Heparin Sodium and Furosemide
Maktabi Briana
, Howard Mitchell S, Baki Gabriella, Churchwell Mariann D
Nov/Dec 2022
Pg. 522-526

Return to Top